T1	Intervention 30 69	YM17E, an inhibitor of acyl coenzyme A:
T2	Intervention 205 254	YM17E, a novel inhibitor of acyl coenzyme A (CoA)
T3	Intervention 447 482	YM17E was administered after a meal
T4	Intervention 1384 1440	150 mg YM17E in both the fasted and post-prandial states
T5	Intervention 1625 1753	received test drug at 150 mg or 300 mg (n = 6 each) or placebo (n = 3) twice a day (after breakfast and after dinner) for 7 days
